With the current trends of COVID-19 disease transmission and case rates in Colorado, the healthcare system could potentially be overwhelmed in the coming weeks. Hospitals and clinics are struggling to provide care due to the increased volume of COVID cases.
Monoclonal antibody (mAb) therapies are one of the few authorized treatments for COVID patients in the ambulatory setting and are proven to be effective at:
shortening COVID symptom duration
preventing severe illness, hospitalization, and death from COVID for patients at high risk of progression to serious disease
And yet, mAb therapies are vastly underutilized in the ambulatory setting. Recent survey data and on-the-ground experience indicate questions about administration, access, and ordering mAb therapies prevent health care providers from maximizing the use of this treatment.
This 60-minute webinar—a statewide collaboration led by the Colorado Department of Public Health and Environment—offers concise, actionable information followed by a live Q&A with clinical and implementation experts. Please choose from three sessions below:
This webinar will be reviewed and accepted for up to 1 CME credit by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity (1.0 credit).